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Abstract 
We report the design and development of a dual-functional magnetic nanoparticle platform 
for potential treatment of H. pylori infection. We show that an ultralow concentration of 
Mn0.3Fe2.7O4@SiO2 nanoparticles subjected to a moderate AC magnetic field, without bulk 
heating effect, can deposit heat locally and effectively inhibit H. pylori growth and virulence 
in vitro. When coupled with antibiotic amoxicillin, the dual-functional amoxicillin loaded 
Mn0.3Fe2.7O4@SiO2 further decreases the bacteria survival rate by a factor of 7 and 5, 
respectively, compared to amoxicillin treatment and nanoparticle heating alone. The 
synergistic effect can be partially attributed to the heating induced damage to the cell 
membrane and protective biofilm, which may increase the permeability of antibiotics to 
bacteria. Our method provides a viable approach to treat H. pylori infection, with the potential 
of reducing side effects and enhancing the efficacy for combating drug resistant strains.   
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1. INTRODUCTION 
Helicobacter pylori (H. pylori) infection is a common chronic infectious disease, affecting 
approximately 4.4 billion individuals worldwide.[1] H. pylori causes chronic active gastritis in 
all colonized subjects. Furthermore, it can lead to peptic ulcer disease, atrophic gastritis, gastric 
adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. [2-4] In 1994, H. pylori 
was classified as a member of first class carcinogen of stomach adenocarcinoma. H. pylori uses 
its flagella to burrow into the mucus lining of the stomach to reach the epithelial cells 
underneath and adhere to them, [5] where it produces biochemicals such as vacuolating 
cytotoxin A, which can cause inflammation and potentially carcinogenesis. [6-8] A recent study 
indicated that H. pylori eradication reduced the cumulative incidence of gastric cancer in 
healthy asymptomatic population, and the effect of H. pylori eradication on the prevention of 
gastric cancer was observed in all ages.[9]  
Current consensus recommends traditional bismuth quadruple therapy for 14 days as one 
of the options for first-line therapy of H. pylori infection.[10] Antibiotics such as metronidazole, 
clarithromycin and amoxicillin are commonly used in the regimens. However, the rapid 
emergence and dissemination of antibiotic-resistant strains has been documented globally.[ 8, 
11] Resistance of H pylori to antibiotics has reached alarming levels worldwide. [12] The reported 
prevalence of clarithomycin resistance among H. pylori was approximately 50% in China, and 
40% in Turkey. [13] While the prevalence of metronidazole resistance was as high as 90% in 
some Asian countries. [13-15] The resistance rate to amoxicillin of H. pylori is also rising. [16] 
Besides, side-effects of antibiotics may make them poorly tolerated by some patients. [17, 18] 
Therefore, it is imperative to explore new treatment methods that can reduce or even avoid the 
use of antibiotics.  
It has been reported that H. pylori survived for less than 1 day at 40 C or 42 C [19]. 
However, human body cannot tolerate a temperature of 42 C for a time duration of 24 h.   On 
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the other hand, thermal energy delivered locally has been employed as a novel method of 
triggering biological responses for various medical applications. [20-24] Recently, it was reported 
that bacterial viability was significantly reduced by photothermal effect. [25-27] However, the 
small penetration depth of light severely limits the clinical potential of photothermal therapy. 
[28] It is well known that magnetic nanoparticles (NPs) exposed in an alternating current (AC) 
magnetic field can be used to deposit heat locally for magnetic hyperthermia and for triggering 
neuronal responses. [29-32] Magnetic hyperthermia has attracted great interests in cancer therapy, 
due to its ability to penetrate deep into the body and its minimal invasiveness. [33] We therefore 
hypothesize that magnetic NP local heating may be used for H. pylori growth inhibition. We 
further hypothesize that local heating in conjunction with antibiotics may synergistically 
enhance H. pylori growth inhibition, thus reduce the antibiotic usage and address the problem 
of antibiotic resistance. Based on the above hypotheses, we designed amoxicillin loaded 
Mn0.3Fe2.7O4@SiO2 NPs as a dual functional agent for local heating and drug carrier. We report 
two significant findings based on in vitro experiments: (1) Local heating by an ultralow 
concentration ( 1 µg/ml) of Mn0.3Fe2.7O4@SiO2 NPs can strongly inhibit the H. pylori bacteria 
growth without bulk heating and (2) using amoxicillin loaded Mn0.3Fe2.7O4@SiO2 NPs as a 
dual functional platform, combined NP local heating and antibiotics show synergistic 
enhancement of H. pylori growth inhibition, with a bacteria survival rate that is just 1/5 and 
1/7 of the values for NP heating and amoxicillin alone. These findings pave the way for clinical 
treatment of H. Pylori infection using our novel approach.  
2. MATERIALS AND METHODS 
2.1. Materials 
H. pylori standard strain NCTC 11637 was kindly provided by the H. pylori Strain Pool, 
Beijing, China. H. pylori medium and Broth medium were purchased from Hopebio, China. 
Cyclohexane and ammonia hydroxide were purchased from Alfa. IGEPAL CO-520 and 
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Tetraethyl orthosilicate (TEOS) were purchased from Sigma-Aldrich Inc., USA. Amoxicillin 
were purchased from Adamas. Campylobacter Agar Base were purchased from OXOID.  
2.2. Preparation and characterization of Mn0.3Fe2.7O4@SiO2 NPs 
Mn0.3Fe2.7O4  NPs were synthesized by high temperature organic solution phase reaction 
method. Iron(III) acetylacetonate (2 mmol), manganese(II) acetylacetonate (1 mmol), 1,2-
hexadecanediol (10 mmol), oleic acid (3 mmol), oleylamine (3 mmol), and 20 mL benzyl ether 
was mixed by magnetic stirring. First, the mixture was heated to 120 ℃ and maintained for 0.5 
h under a flow of nitrogen, then heated to 200 ℃ and kept for 1 h. The temperature was further 
raised to 300 ℃ at a heating rate of 10 ℃/min, and kept at 300 ℃ for 1 h. After the reaction, 
the heat source was removed and the reaction products were cooled down to room temperature. 
The NPs were precipitated from the solution by adding ethanol and centrifugation. The 
collected particles were redispersed in hexane for preservation. The NPs were coated with a 
silica shell by a reverse microemulsion method. 1.15 ml CO-520, 20 ml cyclohexane and 20 
mg Mn0.3Fe2.7O4 NPs were mixed in a 100 ml round bottom flask. After mixing for 20min, 0.15 
ml ammonium hydroxide (28-30%) was added. Finally, 0.15 ml TEOS were added dropwise, 
and the solution was stirred for 24 h. The resulting Mn0.3Fe2.7O4@SiO2 NPs were washed and 
precipitated by adding ethanol and centrifuged. Finally, the Mn0.3Fe2.7O4@SiO2 NPs were 
dispersed in deionized water. 
2.3. Cytotoxicity of Mn0.3Fe2.7O4@SiO2 NPs on SGC-7901 cells and H. pylori  
Human gastric cancer cell line SGC-7901 cells were seeded in a 96-well plate (3000 cells 
/ 100 μl / well) and cultured overnight. Cells were then incubated with different concentrations 
of NPs (0 µg/ml, 50 µg/ml, 100 µg/ml, 150 µg/ml, 200 µg/ml, 250 µg/ml, 300 µg/ml) for 24 h 
or 48 h. After that, CCK-8 solution (10 µl/well) was added to each well and the plate was 
incubated at 37 °C for 40 min in the dark. The optical density (OD) values of each well were 
measured by a spectrophotometer at a wavelength of 450 nm to quantify the cell growth in each 
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group.  
H. pylori NCTC 11637 were used throughout the experiments. H. pylori was grown 
in Campylobacter agar base containing 5% sheep blood under microaerobic conditions (5% 
O2, 10% CO2, and 85% N2) at 37°C for 2–3 days. Different concentration of NPs (1 µg/ml, 10 
µg/ml, 20 µg/ml, 50 µg/ml, 100 µg/ml, 200 µg/ml) was added into the agar base, then 
H. pylori was inoculated and cultured for 3 days. Finally, colonies of bacteria were observed.   
For the morphology and adhesion ability analyses, H. pylori was grown in Broth Medium. 
2.4. Effect of Mn0.3Fe2.7O4@SiO2 NP heating on H. pylori growth  
H. pylori culturing agar medium containing Mn0.3Fe2.7O4@SiO2 NPs (1 µg / ml) was 
prepared. H. pylori in logarithmic growth phase was collected by phosphate buffer solution 
(PBS), 1.2 x 107 colony forming unit (CFU) colonies were added to each 3 cm diameter culture 
dish. After being evenly coated, the H. pylori were cultured in a 37 °C incubator for 12 h. The 
culture dish was placed in an AC magnetic field coil to heat the culture medium and the 
temperature of the culture medium was recorded with a fiber-optical thermocouple. The culture 
dishes after heat treatment were incubated at 37 °C for 72 h. Finally, each group of H. pylori 
was collected with PBS, and the absorbance of each group was detected by spectrophotometer 
at a wavelength of 600 nm（optical density measured at 600 nm, OD600), which was used to 
quantify the H. pylori survival rate of each group.  
2.5. Morphology of H. pylori observed by transmission electron microscopy (TEM) 
H. pylori grown in Broth Medium containing Mn0.3Fe2.7O4@SiO2 NPs (0.4 µg / ml) was 
placed in an AC magnetic field. The culture medium temperature was raised to 41°C and kept 
at that temperature for 10 min. It was then incubated at 37 °C for 2 h. The supernatant was 
discarded after centrifugation for 4 min at a rate of 1500 r/min. The bacterial concentration was 
adjusted to 108 CFU/ml by using the 3% glutaraldehyde fixation solution to resuspend the H. 
pylori pellet, and the bacteria were fixed by placing them in a refrigerator at 4 °C. 10 μl of H. 
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pylori bacterial liquid was dropped on the amorphous carbon-coated copper grids and let dry. 
One drop of 3% phosphotungstic acid dye solution was added for negative staining. TEM 
(JEOL-2100) was employed to observe the morphological change of the bacteria.  
2.6. Evaluation of H. pylori adhesion ability  
H. pylori grown in Broth Medium was cultured at 37 ℃ in microaerobic environment for 
2 h after different treatment. The bacteria were collected (1500 r/min, 4 min) and dissolved in 
RPMI-1640 medium without antibiotics and serum, to form H. pylori-RPMI-1640 solution, 
and then adjusted to OD600 = 0.1 for standby. SGC-7901 cells in logarithmic growth phase were 
seeded in 96-well plate with 1 × 104 cells/well, and cultured in incubator at 37 °C overnight. 
The as-treated bacteria liquid were added for co-cultivation for 2 h with the ratio of bacteria: 
cells = 100: 1. The supernatant was discarded and then the cells were washed with PBS for 
three times to wash away cell debris and non-adhering H. pylori. 100 μl urea reagent was added 
into each well, and incubated for 2 h at room temperature. The absorbance of each group was 
measured with a spectrophotometer with a wavelength of 540 nm. 
2.7. Preparation of amoxicillin loaded Mn0.3Fe2.7O4@SiO2 NPs and detection of amoxicillin 
release 
1 ml of amoxicillin standard solution of different concentrations (0 µg/ml, 20 µg/ml, 30 
µg/ml, 40 µg/ml, 50 µg/ml, 60 µg/ml) were detected by high performance liquid 
chromatography (HPLC) (Agilent 1100), and the peak areas of different concentration of 
amoxicillin was recorded to draw the standard curve of peak area concentration. 1 ml of 
Mn0.3Fe2.7O4@SiO2 solution (10 mg/ml) was added into 9 ml amoxicillin solution (1.5 mg/ml), 
then stirred continuously for 8 h at room temperature. The mixture was placed under a NdFeB 
magnet for 12 h at room temperature. The NPs were precipitated to the bottom; the supernatant 
removed and stored under 4 ℃. The NPs that were adsorbed to the bottom were dissolved in 
1ml double-distilled water. The solutions were then subjected to HPLC to detect the 
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concentration of amoxicillin. The drug-loading of amoxicillin loaded magnetic NPs was 
therefore deduced. Drug loading content were calculated as follows: rate of drug loading (%) 
= (total amoxicillin amount – amoxicillin amount in supernatant)/total amoxicillin amount.  
2.8. Detection of surface potential of NPs 
1 mg/ml amoxicillin sodium chloride solution, 1 mg/ml Mn0.3Fe2.7O4@SiO2 sodium 
chloride solution and 1 mg/ml amoxicillin loaded Mn0.3Fe2.7O4@SiO2 sodium chloride solution 
were prepared, respectively. The surface potential of these samples was measured using a 
Malvern Zetasizer Nano ZS90 nanoparticle size potential analyzer. 
2.9. Detection of amoxicillin minimum inhibitory concentration (MIC) on H. pylori 
The campylobacter agar mediums with amoxicillin concentration gradient of 20 μg/ml, 10 
μg/ml, 5 μg/ml, 2.5 μg/ml, 1.25 μg/ml, 0.625 μg/ml, 0.3125 µg/ml, 0.15625 µg/ml, 0.078125 
µg/ml, 0.0390625 µg/ml and 0 µg/ml were prepared respectively, according to the National 
Committee for Clinical Laboratory Standards (NCCLS). H. pylori in logarithmic growth phase 
was collected by PBS and dispensed to a concentration of OD600 = 1 (about 3 × 10
8 CFU/ ml). 
40 μl of the bacteria liquid was added to each 3 cm culture dish, and spread evenly. The culture 
dishes were placed inertly in microaerobic gas bags and cultured at 37 ℃ in incubator for 72 h 
to observe the colony formation of each group. 
2.10. H. pylori growth inhibition by amoxicillin loaded Mn0.3Fe2.7O4@SiO2 NPs 
The media containing amoxicillin, Mn0.3Fe2.7O4@SiO2, and amoxicillin loaded 
Mn0.3Fe2.7O4@SiO2 NPs were prepared and grouped according to heating/no heating and 
heating methods. 40 μl of H. pylori bacteria solution (OD600 = 1) was inoculated into a petri 
dish with diameter of 3 cm, and cultured in incubator at 37 ℃ for 12 h. Groups B1 and C1 were 
placed in AC magnetic field, so that the medium temperature reached 41 ℃ and the temperature 
was maintained for 10 min; Group D1 was heated in a water bath and maintained at 41 ℃ for 
10 min; Groups A / B2 / C2 / D2 were cultured at 37 ℃ as control groups. After the treatment 
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described above, the petri dishes were placed in an incubator and cultured at 37 ℃ for 72 h. H. 
pylori in each group was collected by PBS, and the absorbance of each group was detected 
with a spectrophotometer with wavelength of 600 nm. 
2.11. H. pylori colony forming test 
H. pylori agar media containing amoxicillin, Mn0.3Fe2.7O4@SiO2 and amoxicillin loaded 
Mn0.3Fe2.7O4@SiO2 NPs were prepared. 3 × 10
4 CFU of H. pylori was inoculated into a 3 cm 
diameter petri dish. The culture dish of group B1 and C1 was heated in an AC magnetic field, 
and the temperature of the medium was kept at 41 ℃ for 10 min. The D1 medium was placed 
in a 41 ℃ water bath for 10min. Group A/B2/C2/D2 were unheated control groups and cultured 
at 37℃ . After the above treatments, the culture dishes were placed in a microaerobic 
environment at 37°C for 72 h, and the colony forming units in each group was observed. 
2.12. Statistical analyses 
The experimental data were expressed as mean ± standard deviation (SD). SPSS19.0 
(IBM Corp., Armonk, NY, USA) was used to analyze the data. Univariate comparisons 
between two groups were made using Student’s t test for normally distributed data, Wilcoxon 
rank sum for skewed data. Comparisons of measurement data among multiple groups were 
analyzed by one-way analysis of variance (ANOVA). P < 0.05 was indicative of statistical 
significance. 
 
3. EXPERIMENTAL RESULTS 
Our approach is shown schematically in Fig. 1. Mn0.3Fe2.7O4 NPs were synthesized by 
high temperature organic solution phase reaction of metal acetylacetonates and 1,2-
hexadecanediol in the presence of oleic acid and oleylamine. [34] Silica coating of NPs was 
performed using reverse microemulsion method. [35] Amoxicillin was coupled to silica shells 
of Mn0.3Fe2.7O4@SiO2 NPs by electrostatic interactions forming amoxicillin loaded 
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Mn0.3Fe2.7O4@SiO2 NPs. H. Pylori growth inhibition were systematically investigated in the 
presence of AC field heating of magnetic NPs and amoxicillin for the dual functional agent, 
and compared to that of NP heating and amoxicillin separately. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A schematic of our approach using amoxicillin loaded Mn0.3Fe2.7O4@SiO2 NPs dual 
functional agent for H. Pylori growth inhibition. The results were compared to using NP 
heating and amoxicillin separately. 
Monodisperse, highly crystalline and high magnetic moment Mn0.3Fe2.7O4 NPs with a 
diameter of 22 nm were synthesized by a one-pot thermal decomposition method, and used as 
a model drug carrier system. [34] Our previous study shows that soft ferrite NPs with relatively 
large size possess high specific loss power (SLP) at moderate AC field amplitudes.[22] However, 
when the NP sizes are larger than 22 nm, they become ferromagnetic and tend to agglomerate 
in the solution due to strong magnetostatic interactions. This puts the upper size limit of these 
ferrite NPs at around 22 nm. Fig. 2 (a) shows a TEM image of monodisperse 22 nm 
Mn0.3Fe2.7O4 NPs. Electron diffraction pattern shown in the inset of Fig. 2 (a) confirms the 
spinal structure of the NPs with excellent crystallinity. As-synthesized NPs can be dispersed in 
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hexane in the presence of oleic acid and oleylamine. For bio-applications, the surface of NPs 
was modified by silica coating to make them water-soluble and biocompatible. Silica has been 
widely used in biomedical applications, because of its merits of high stability in a wide range 
of pH [20, 36], ease of functionalization, and biocompatibility. A typical TEM image of 
Mn0.3Fe2.7O4@SiO2 NPs is shown in Fig. 2 (b). The silica shells were kept thin with a thickness 
of 4-5 nm, and reaction parameters were controlled so that no free silica particles were present. 
Aqueous dispersions of Mn0.3Fe2.7O4@SiO2 remain stable without agglomeration for over 2 
years. [22] 
The magnetic hysteresis loops of Mn0.3Fe2.7O4 NPs were measured at 300 K and 5 K, as 
shown in Fig. 2 (c). Mn0.3Fe2.7O4 NPs are superparamagnetic at 300 K, while exhibiting 
ferromagnetism at 5 K (see inset of Fig. 2 (c)). The saturation magnetization S of Mn0.3Fe2.7O4 
NPs is 96.5 emu/g at 5 K and 85.5 emu/g at 300 K, close to the bulk values and among the 
highest values for manganese-ferrite NPs. The high saturation magnetization is due to the high 
crystallinity of the NPs resulting from the polyol synthesis process.[37] The bulk S value is 112 
emu/g for MnFe2O4 and 98 emu/g for Fe3O4 at 0 K,
[38] and the bulk S value for Mn0.3Fe2.7O4 
is expected to be ~ 102 emu/g.  We estimate a 5% reduction in S for NPs compared to bulk 
value, which can mainly be attributed to surface spin disorder due to changes in coordination 
numbers that modifies the exchange interaction.[39] At a diameter of 22 nm, if we assume that 
Fe + Mn atoms located at up to half a unit cell thick surface layer lose their magnetic moment 
completely, it would amount to a reduction of 12% in S.  Note however, ferrites have 
antiferromagnetic super-exchange, and missing nearest neighbor atoms at the surface does not 
necessarily lead to moment reduction.  
The coercivity HC at 5 K is 205 Oe (16.3 kA/m), from which the magnetic anisotropy 
energy can be estimated by 𝑀𝑆𝐻𝐾  𝑀𝑆𝐻𝐶 , where HK is the anisotropy field that can be 
approximated by HC at low temperatures. The anisotropy energy value is thus estimated to be 
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1.0×105 erg/cm3 (1.0×104 J/m3), which is in between the bulk cubic anisotropy constants of 
MnFe2O4 and Fe3O4. Surface anisotropy may make additional contributions due to surface spin 
canting, and change the type of anisotropy from cubic to uniaxial.  
Other than magnetization, the single most important parameter for evaluating the 
hyperthermia performance is the HC of the AC hysteresis. However, most labs are not equipped 
to measure the magnetic hysteresis loops at the frequency and field amplitude typically used 
for hyperthermia. On the other hand, DC measurements at room temperature will simply give 
superparamagnetic hysteresis loops with zero coercivity. As a compromise, one may estimate 
the anisotropy field HK at 300 K, assuming that anisotropy decreases as a power of the reduced 
magnetization:  
𝐾𝑢
𝐾𝑢,0
∝ (
𝑀𝑆
𝑀𝑆,0
)
𝑛
 
where n is 3 for uniaxial anisotropy [38], and Ku,0 and MS,0 are quantities at 0 K, which can be 
substituted by the values measured at 5 K without significant error. HK at 300 K thus estimated 
is 160 Oe (12.8 kA/m). For AC hysteresis loss to occur, the field amplitude should be larger 
than HK or magnetization cannot be reversed, leading to very low SLP.   
Heating curves of aqueous dispersions of Mn0.3Fe2.7O4@SiO2 NPs with a concentration of 
1 mg/ml exposed to AC magnetic fields of 380 kHz and field amplitudes ranging from 14 to 
33 kA/m were measured by a fiber optical thermometer, as shown in Fig. 2 (d). In the present 
work, the minimum field amplitude used was 14 kA/m, greater than the estimated HK of the 
NPs at 300 K, as SLP is expected to be low for fields below HK. Contribution from pure water 
under identical conditions was also measured and subtracted as the background. SLP of NPs 
was extracted using Box-Lucas fitting, since the measurements were performed under non-
adiabatic conditions. [40] SLP vs magnetic field amplitude was plotted in Fig 2 (e). It can be seen 
that SLP of Mn0.3Fe2.7O4/SiO2 NPs increases monotonically with increasing magnetic field 
amplitude, from ~ 1,200 W/g at H = 14 kA/m to ~ 2,500 W/g at H = 33 kA/m. The intrinsic 
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loss power (ILP), defined as SLP/H2f, are 16.4 and 6.0 nHm2/kg, respectively (see Fig. 2 (f)). 
Note that ILP values are reported here strictly for the purpose of comparison to results from 
literature. Due to a lack of standards in magnetic hyperthermia measurements, ILP was 
introduced previously to compare heating performance of NPs measured under different field 
parameters based on linear response theory, and thus SLP scales linearly with H2 and ILP 
should be field-independent.[41] This is clearly not the case here, as seen from Fig. 2. Moreover, 
majority of the magnetic hyperthermia work used field amplitudes exceeding those required by 
the linear response theory, and thus there is little physical significance of ILP. Our SLP and 
ILP values are significantly higher than earlier reported results for magnetite and manganese 
ferrite NPs, [33, 42, 43] suggesting that the Mn0.3Fe2.7O4@SiO2 NPs possess adequate heating 
performance, and therefore are good candidates for studying H. pylori inhibition by delivering 
local heat.  
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To study the effects of NP local heating on the inhibition of H. pylori growth in vitro, H. 
pylori culturing agar medium containing 1 µg/ml Mn0.3Fe2.7O4@SiO2 NPs were subjected to 
an AC magnetic field of 380 kHz and varying amplitude for 15 minutes. This chosen NP 
concentration is three orders of magnitude lower than what is needed for bulk solution heating 
(Fig. 2 (e)), and thus the heat energy deposited by NPs is insignificant to raise the agar medium 
background temperature. The AC magnetic field itself does lead to background heating of the 
campylobacter agar medium.  For example, the top panel in Fig. 3 (a) shows the measured 
temperature of the agar medium subjected to an AC field of 17.5 kA/m for 15 min. After 7 min 
heating, the background temperature (Tb) was stabilized at 41 C. Adding NPs with a 
concentration of 1 µg/ml leads to almost no change in the background heating profile, as seen 
from the bottom panel in Fig 3 (a). When the agar medium was heated at 42 C by an AC field 
for a time duration of 15 min, this background heating at Tb did not alter the viability of H. 
Pylori (Fig. 3 (b)), but can serve as a measure of the local heat energy deposited by NPs on the 
bacteria (which cannot be measured directly due to limited spatial resolution of the 
thermocouple), as both would increase with the field amplitude proportionally. OD600 value of 
each group was used to quantify the bacterial growth inhibition rate. 
Figure 2. (a) A typical TEM image of monodisperse Mn0.3Fe2.7O4 NPs and an electron 
diffraction pattern of the NPs showing spinel structure; (b) a typical TEM image of 
Mn0.3Fe2.7O4@SiO2 NPs; (c) the magnetic hysteresis loops of as-synthesized Mn0.3Fe2.7O4 
NPs at temperatures of 5K and 300K, the inset plots the hysteresis loops in a smaller field 
range, showing ferromagnetic behavior at 5 K;  (d) the AC field heating curves measured at 
380 kHz and varying field amplitude, for NPs with a concentration of 1 mg/ml; (e) field 
dependence of SLP for Mn0.3Fe2.7O4@SiO2 NPs; (f) field dependence of ILP for 
Mn0.3Fe2.7O4@SiO2 NPs  
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The growth inhibition rate of H. pylori cultured on NPs-containing agar medium increases 
monotonically with increasing Tb from 37 ℃ (14 kA/m) to 42 ℃ (18 kA/m) for a fixed heating 
time of 15 min, as shown in Fig. 3 (c). It is seen that with increasing AC field amplitude so that 
Tb in the medium was raised to 41 C, the inhibition rate of H. pylori growth was 75%. This 
value further increases to 96% when Tb was increased to 42 ℃. The time-dependent H. pylori 
inhibition at Tb = 42 ℃ was investigated, as shown in Fig. 3 (d). With the extension of heating 
time, the growth inhibition rate of H. pylori increases monotonically from 18% for the heating 
time of 1 min to 96% for 15 min.  
Cytotoxicity of NPs to SGC-7901 cells and H. Pylori was investigated in order to rule out 
the direct inhibitory effect of Mn0.3Fe2.7O4@SiO2 NPs on both mammalian and bacterial cell 
growth. Compared to the group without NPs, the group containing 100 µg/ml 
Mn0.3Fe2.7O4@SiO2 NPs showed no significant difference in cell viability at the incubation 
time of up to 48 h (Fig. 4). The inhibition of H. pylori growth by AC field background heating 
of the agar medium without NPs and by water bath at 42 ℃, for a time duration of 15 min, was 
also measured for comparison. No significant growth inhibition was observed in either case 
(Fig. 3 (b)). This suggests that the H. pylori inhibition is not due to the global heating of the 
medium, but due to the local heat energy deposited on the bacteria surfaces immediately 
adjacent to the NPs. Previous studies by our group and others suggest that during AC field 
heating, the local temperatures at the cell membranes immediately adjacent to the NPs are 
significantly higher than the environment temperature measured by a thermometer, albeit the 
low spatial resolution of the fiber-optical thermocouple prevents direct measurement of such 
local temperatures. [21, 44] Thus AC field heating of magnetic NPs is advantageous as it can 
deliver targeted heating without raising the environment temperature significantly and causing 
collateral damages to healthy cells or tissues.   
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Figure 3. (a) Temperature vs time curve of H. pylori culturing agar medium exposed in AC 
field of 380 kHz, 17.5 kA/m. Top panel: without NPs; bottom panel: with addition of 1 µg/ml 
NPs. The medium temperature Tb was stabilized at 41 ℃ ± 0.5 C; (b) H. Pylori growth under 
the AC field without NPs and in water bath heated at 42 ℃ for 15 min. No significant growth 
inhibition was observed in each group; (c and d) Effect of Mn0.3Fe2.7O4@SiO2 heating on H. 
pylori growth inhibition: Percentage of H. Pylori growth inhibition (c) as a function of Tb, t 
=15 min under the field of 380 kHz; (d) as a function of time, Tb = 42 C under the field of 
380 kHz, 18 kA/m. 
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Figure 4. Cytotoxicity of Mn0.3Fe2.7O4@SiO2 NPs to SGC-7901 cells. * P<0.05, compared 
with 0 µg/ml group (control group). 
The above experiments confirm that NP local heating is effective in H. pylori inhibition 
at an ultralow NP concentration of 1 µg/ml incapable of inducing bulk heating. To elucidate 
the mechanisms of H. pylori growth inhibition, TEM images of the bacteria before and after 
NP heating (Tb= 41 C for 15 min) was done to investigate possible changes in bacteria 
morphology. According to Fig. 3 (c), the bacteria growth inhibition was 75% under this 
treatment condition. It was found that the morphology of the H. pylori after NP heating changed 
dramatically, as seen in Fig. 5. Untreated H. pylori typically appears to be a unipolar, blunt-
ended rod with a length of about a few μm and a flagellum with sheath on one end, and the 
density of the whole cell body was uniform, as shown in Fig. 5 (a) and (b). In the close-up view 
of a single bacterium, a scrub-like biofilm was observed surrounding the cell after negative 
staining (Fig. 5 (b)). The biofilm is a matrix containing extracellular polymeric substances to 
embed bacteria, [9] which plays a main role in the antibiotic resistance. After NP heating, 
however, the morphology of the H. pylori changed dramatically, as seen from Fig. 5 (c) and 
5(d). The flagellum and the scrub-like biofilm disappeared. The cell body became swollen with 
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cell membrane damaged. The density of the cell decreased non-uniformly, suggesting that parts 
of the interior of the cell body became hollow. A high concentration of magnetic NPs was 
observed to accumulate on the surface of the bacteria. In the more extreme cases as shown in 
Fig. 5 (d), the bacteria changed shape completely from rod-like to being bent like a “V” shape. 
Such dramatic changes in morphology indicate direct growth inhibition upon NP heating, 
consistent with the inhibition rate of 75% at Tb= 41 C shown in Fig. 3 (c). Based on the TEM 
results, we propose the following mechanisms of H. pylori growth inhibition by NP heating: 1. 
The local heating causes cell membrane rupture, releasing its content, and leads to direct 
bacteria death; and 2. As the flagellum of normal H. pylori can make it swim through gastric 
mucus and bind to the gastric epithelial cells through the secretion of adhesion, the loss of 
flagella will cause the bacteria to lose its mobility and adhesion ability.   
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Figure 5. Effects of NP heating on H. pylori NCTC11637 morphology based on transmission 
electron microscopy. (a) and (b) Untreated normal H. pylori; (c) and (d) NP heating treated H. 
pylori, showing bacteria with lost flagellum and bio-films; (e) changes of H. pylori adhesion 
ability after NP heating treatment. Compared with control groups, the group with 
Mn0.3Fe2.7O4@SiO2 NP heating showed significant inhibition of the adhesion ability. * P < 
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0.05, vs. the control group (n = 5).  
The changes of the H. pylori adhesion ability after NP heating were measured. Compared 
with the control group, the NPs heating group, which was heated in AC magnetic field at Tb = 
41 ℃ for 10 min, showed an adhesion inhibitory rate of 51.78%, while either water bath group 
or NP without heating group exhibited no significant statistical difference as seen from Fig. 5 
(e). These results confirmed one major mechanism of NP heating induced H. pylori growth 
inhibition: the localized heating leads to morphological changes of the bacteria. Specifically, it 
causes the bacteria to lose its flagellum, which prevents H. pylori from adhering to cells.  
The NP heating induced bacteria growth inhibition, together with the observed change in 
bacteria morphology and adhesion ability is interesting. It seems to be inconsistent with what 
was predicted from classical heat diffusion model. Using this model, it has been suggested that 
at a concentration of 1 mg/ml, typical magnetic NPs with a SLP of a few 100 W/g are incapable 
of reaching the therapeutic temperature of 42 C for a tumor size smaller than 3 mm. [45] 
However, our effective NP concentration was three orders of magnitude lower. The sizes of 
the cultured bacteria clusters, on the other hand, were 1 mm or smaller. Recently, however, 
more experimental evidence emerged to show that local temperatures in the vicinity of cell 
surfaces may be dramatically different from the global temperature measured by a 
thermocouple. [46, 47] We propose two scenarios that might explain this apparent discrepancy: 
1. The local concentration of NPs in the vicinity of the bacteria surface is much higher than the 
nominal one, as evidenced in Fig. 5. The collective behavior of these NPs can heat the bacteria 
surface to temperatures much higher than those measured by a fiber-optical thermocouple, 
which does not have the spatial resolution to resolve the local temperature. These local “hot 
spots” may be the ones making dominant contributions to thermal energy deposition and cell 
damage; 2. The ordered structure of cell membranes may lead to quasi-ballistic thermal 
transport, when the size of the heat generating region is smaller than the phonon mean free 
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path. This may lead to a much higher temperature rise and a sharp temperature gradient at the 
cell surface.[48] Future studies focusing on non-uniform distribution of NPs in biological 
systems and reliable characterization of local temperature at the nanoscale are needed to clarify 
the origin of the observed local heating. Such studies are of great significance as nanoscale 
local heating may enable treatment of small tumors and metastasis cancer cells. 
Although the direct growth inhibition rate was at 75% for Tb= 41 C for 15 min, the 
remaining survival bacteria may still be affected by NP heating. From the TEM studies, a 
universal feature exhibited by almost all bacteria was that the biofilms were destroyed by NP 
heating. A recent study reported that local hyperthermia induced by iron oxide nanoparticles 
can disperse biofilms of Pseudomonas aeruginosa, and increase its susceptibility towards 
antimicrobials. [49] We postulate that if antibiotics were administered simultaneously with NP 
heating to H. pylori, there would be a synergistic effect on bacterial inhibition. As amoxicillin 
is presently one of the most commonly recommended antibiotics used for H. pylori eradication 
during clinical practices, it would be interesting to study the combined effects of amoxicillin 
and NP heating. To test this aspect, we designed an amoxicillin loaded Mn0.3Fe2.7O4@SiO2 
dual functional NP platform, relying on electrostatic coupling between the antibiotic and NPs. 
It is known that NPs with a silica shell possess high negative surface charges. [50] On the other 
hand, amoxicillin molecules were detected to have a zeta potential level showing small positive 
charges. [51] We postulate that Mn0.3Fe2.7O4@SiO2 NPs and amoxicillin can be coupled directly 
by electrostatic interactions to form amoxicillin loaded Mn0.3Fe2.7O4@SiO2. The zeta potential 
was measured to confirm the coupling. It was found that the zeta potential of amoxicillin was 
7.022 mV and that of Mn0.3Fe2.7O4@SiO2 NPs was -46.02 mV, as shown in Fig. 6(a) and (b), 
respectively. After coupling, the zeta potential value of amoxicillin-Mn0.3Fe2.7O4@SiO2 was 
measured to be -40.02 mV (Fig. 6 (c)). This shows that the presence of positively charged 
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amoxicillin reduces the negative surface charge of Mn0.3Fe2.7O4@SiO2 NPs, suggesting 
successful binding of the antibiotic to NPs.  
The MIC of amoxicillin to H. pylori, i.e. the lowest concentration of amoxicillin which 
prevents visible growth of the bacteria, was found to be 0.078 μg/ml. To study potential 
synergistic effects of NP heating and amoxicillin delivery, 0.04 μg/ml amoxicillin, about a half 
of the MIC was chosen as the antibiotic concentration used in this experiment. As the drug 
loading ratio of amoxicillin loaded Mn0.3Fe2.7O4@SiO2 was measured to be 10.4%, the 
concentration of Mn0.3Fe2.7O4@SiO2 NPs used was 0.4 μg/ml. Note that the NP concentration 
was below the values of 1 μg/ml used above for testing heating effect alone (Fig. 3). H. pylori 
was treated by different methods summarized in Table 1 for comparing their effectiveness of 
growth inhibition. When AC field heating was present, the field amplitude was controlled so 
that the background temperature Tb was kept at 41 ℃ for 10 min (Fig. 3 (a)). The bacterial 
colony forming units of H. pylori were shown in Fig. 6(d), revealing qualitative difference after 
different treatments. The quantitative bacteria growth inhibition measured by OD600 was 
further plotted in Fig. 6(e). The control groups, namely Mn0.3Fe2.7O4@SiO2 NPs without 
heating (group C2) and the group treated at 41 ℃ in water bath (group D1) had no effect on H. 
pylori growth inhibition. Compared with the control groups, amoxicillin treatment group 
(group A), Mn0.3Fe2.7O4@SiO2 NP heat treatment group (group C1) and amoxicillin loaded 
Mn0.3Fe2.7O4@SiO2 NP heat treatment group (group B1) all showed significant growth 
inhibition. The effect of group C1 is significantly better than that of group A. As can be seen 
from Fig. 6(e), amoxicillin treatment alone (group A) results in cell survival rate of 43.7%, 
while NP heating alone (group C1) leads to cell survival of 23.7%, which is nearly 50% 
reduction compared to group A. The inhibition effect of the amoxicillin loaded 
Mn0.3Fe2.7O4@SiO2 heat treatment group (group B1) is the highest, with the cell survival being 
only 6.15% of that of the blank control group. From these data, it can be seen that the NP 
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heating combined with amoxicillin treatment greatly enhances H. pylori growth inhibition, 
decreasing the bacteria survival rate by a factor of 7 and 5, respectively, compared to 
amoxicillin treatment and NP heating alone. 
 
Table 1. Summary of groups with different treatment methods 
Group AC magnetic 
field 
Reagents/treatment added Final concentration of 
reagents added 
Inhibitory 
rate(%) 
A No Amoxicillin 0.04µg/ml 56.34 
B1 Yes Amoxicillin-Mn0.3Fe2.7O4/SiO2 0.4µg/ml（Amoxicillin: 
0.04µg/ml） 
93.86 
 B2 No Amoxicillin-Mn0.3Fe2.7O4/SiO2 0.4µg/ml（Amoxicillin: 
0.04µg/ml） 
41.47 
C1 Yes Mn0.3Fe2.7O4/SiO2 0.4µg/ml 76.26 
C2 No Mn0.3Fe2.7O4/SiO2 0.4µg/ml 11.87 
D1 No Water bath NA 18.28 
D2 No No NA 0 
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Figure 6. Zeta potential of (a) Mn0.3Fe2.7O4@SiO2 NPs; (b) amoxicillin and (c) amoxicillin 
loaded Mn0.3Fe2.7O4@SiO2 NPs; (d) Bacterial colony forming units of H. pylori in different 
treatment groups, D2 served as positive control, WT was negative control; (e) H pylori growth 
after different treatment. Compared with control group, Mn0.3Fe2.7O4@SiO2 NP with heat 
treatment group, amoxicillin loaded Mn0.3Fe2.7O4@SiO2 NP with/without heat treatment group 
and amoxicillin group all showed significant growth inhibition. The inhibitory effect of the 
amoxicillin loaded Mn0.3Fe2.7O4@SiO2 heat treatment group is the highest. *, P < 0.05, **, P 
< 0.01, ***, P < 0.001, vs. the control group (n = 3).  
 
3. DISCUSSIONS 
The great enhancement in H. Pylori growth and virulence inhibition by amoxicillin loaded 
Mn0.3Fe2.7O4@SiO2 NP heat treatment is exciting. The inhibition rate of combined treatment 
is significantly higher than that of the simple addition of the two separate treatments, 
confirming synergistic effects. The synergy can be understood as follows: the NP local heating 
causes dramatic changes in the morphology of the bacteria. In particular, the heating can open 
up or destroy the biofilm, as seen from Fig. 5(c) and (d). It is known that the biofilm of H. 
pylori is a protective strategy for the bacteria. In addition to helping combating the host immune 
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system and environmental stresses, it can also protect the bacteria from antimicrobial drug 
treatment, resulting in drug resistance. The loss of the biofilm by NP heating can make H. 
Pylori more susceptible to antimicrobial amoxicillin, and thus enhance its efficacy. The reverse 
may also be true, that is the low dosage of amoxicillin below MIC may make H. Pylori more 
sensitive to NP heating, thus increase the direct bacteria apoptosis by NP heating.  
The synergistic effects of antibiotics and NP heating may greatly reduce the dosage of 
antibiotics required in the treatment of H. pylori infection. The approach is particularly useful 
for the treatment of drug resistant strains. Because of high bacterial load [52] and the gastric 
niche, [53] where H. pylori could be protected from both antibiotic action and immune response, 
the drugs has to remain in high concentration for prolonged period in the stomach to display 
its therapeutic effectiveness. The DC magnetic field gradient can in principle be applied to 
localize the NPs in the upper-abdominal area by e.g. wearing a permanent magnet patch, and 
to serve as a part of the gastroretentive drug delivery system. By removing the DC field after 
the treatment, the NPs can be readily excreted through the gastrointestinal tract. As opposed to 
systemic delivery which inevitably leads to accumulation of NPs in organs, our approach will 
have less concern of the potential toxicity of the NPs. We therefore envision that this approach 
can be readily adopted for clinical applications. 
4. CONCLUSION 
In this study, we designed an amoxicillin loaded Mn0.3Fe2.7O4@SiO2 dual functional NP 
platform and demonstrated its antibacterial effect under AC magnetic field heating. It is found 
that the H. pylori growth is significantly suppressed by a factor of 7 and 5, respectively, 
compared to using amoxicillin or NP heating separately, indicating the synergistic effect of NP 
local heating and drug release. NP local heating can not only lead to direct cell disruption and 
loss of adhesion ability, but also enhance the susceptibility of H. pylori to amoxicillin due to 
destruction of cell membrane and microbial biofilm. Our approach provides a new pathway for 
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fighting H. pylori infection, especially for drug resistant ones. Furthermore, the coupling of 
antibiotics to magnetic NPs and utilizing the synergistic effects of NP local heating and drug 
release is a general concept, and can be adopted to fight other infectious diseases with enhanced 
efficacy. 
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